Toggle navigation
Home
Search
Services
Blog
Contact
About
Pediatric Hydroxyurea Phase III Clinical Trial
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Determining the lineage progression of embryonic and adult neural stem cells
Human Antibodies to HIV
Surveillance & Eradication in Global Guinea Worm Eradication Effort
Role of Stretch in Focal Atrial Fibrilation
Systems analysis of the interplay between oxygenic photosynthesis and nitrogen fixation in a unicellular cyanobacterium
Recently added grants:
Role of presynaptic targeting of alpha-synuclein in the pathogenesis of Parkinson's Disease and Dementia with Lewy Bodies
The Impact of Telestroke on Patterns of Care and Long-Term Outcomes
High throughput screen for discovery of N-acetyltransferase 8 Like (NAT8L) inhibitors
Eradication of Escaped Variant Tumor Cells for Cancer Immunotherapy
Subversion of Syndecan-1 Functions in Listeriosis
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research and Development Contracts (N01)
Project #
N01HB07155-16-0-1
Application #
7574917
Study Section
Project Start
2000-09-01
Project End
2009-03-31
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 HL
Pediatric Hydroxyurea Phase III Clinical Trial
/ St. Jude Children's Research Hospital
$456,619
NIH 2007
N01 HL
Pedriatric Hydroxyurea Phase III Clinical Trial Clinical
Wang, Winfred C. /
$496,007
NIH 2007
N01 HL
Pediatric Hydroxyurea Phase III Clinical Trial
/
Comments
Be the first to comment on this grant